NCT06624085 2026-06-03A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaHoffmann-La RochePhase 1 Recruiting50 enrolled